Imidazopiperazinhemmer von transkriptionsaktivierenden proteinen

AT1878252TUndetermined Publication Date: 2026-02-15BOARD OF RGT THE UNIV OF TEXAS SYST

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: AT2021876484T
Authority / Receiving Office: AT · AT
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2020-10-02
Filing Date: 2021-09-30
Publication Date: 2026-02-15
Estimated Expiration: 2041-09-30

Application Information

Patent Timeline

02 Oct 2020

Priority

30 Sep 2021

Application

AT2021876484T

15 Feb 2026

Publication

AT1878252T

IPC: A61K

Inventors: LE, KANG; SOTH, MICHAEL

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.

Need to check novelty before this filing date? Find Prior Art